New cell therapy SUPLEXA shows promise in early cancer trial
Disease control
Completed
This early study tested a new treatment called SUPLEXA in 46 adults with advanced solid tumors or blood cancers that had spread. The main goal was to see if the treatment is safe and tolerable. Patients received repeated infusions of SUPLEXA cells, and researchers monitored side …
Phase: PHASE1 • Sponsor: Alloplex Biotherapeutics Inc • Aim: Disease control
Last updated May 13, 2026 15:59 UTC